Business

Antibody-Drug Conjugates (ADCs) Market Product Scope, Demand, Business Scenario, Trends, Share, and Forecasts 2021 – 2028

The global Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.

Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/754

ADCs are a targeted approach to deliver medicine and chemotherapy agents to cancer cells. Almost 8.2 million persons die each year due to cancer globally. Increasing prevalence of cancer in countries across the globe has created a rapid incline in demand for ADCs. Market players are collaborating to share resources and product knowledge to enhance effectiveness and efficiency of solutions and offerings and to develop even more advanced and effective drugs and therapies.

The Global Antibody-Drug Conjugates (ADCs) Market Research Report is furnished with the latest information about product specifications and portfolio, technological advancement, product type, and manufacturing. Major factors such as revenue, costs, and gross margin are taken into consideration while formulating this report. The report provides extensive data concerning the key market players along with their SWOT analysis, financial standing, technological and product development, and recent strategic business expansion plans.

To know more about the report @ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market

Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018–2028)

Cleavable Linker

Non-Cleavable Linker

Application Outlook (Revenue, USD Billion; 2018–2028)

Blood Cancer

Leukemia

Lymphoma

Brain Tumor

Ovarian Cancer

Breast Cancer

Lung Cancer

Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals

Research Institute

Clinics

Some major players in the market include

Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Detailed Regional Analysis Covers:

North America

Canada

U.S.

Mexico

Europe

Germany

Italy

U.K.

Rest of EU

Asia Pacific

India

China

Japan

South Korea

Rest of APAC

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

U.A.E

Rest of MEA

Objectives of the Report:

Study of the global Antibody-Drug Conjugates (ADCs) market size by key regions, types, and applications with reference to historical data (2018-2019) and forecast (2021-2028)

Industrial structure analysis of the Antibody-Drug Conjugates (ADCs) market by identification of various sub-segments

Extensive analysis of key market players along with their SWOT analysis

Competitive landscape bench marking

Analysis of Antibody-Drug Conjugates (ADCs) market based on growth trends, futuristic outlook, and contribution to the total growth of the market

Analysis of drivers, constraints, opportunities, challenges, and risks in the global Antibody-Drug Conjugates (ADCs) market

Comprehensive analysis of competitive developments such as expansions, agreements, new product launches, and other strategic alliances

Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.

About Us:

At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Leave a Reply

Your email address will not be published.